Tag archive for ‘200 mg and 400 mg’
By editor3 On Tuesday, June 1st, 2021
0 Comments

Glenmark Pharmaceuticals launches Rufinamide Tablets USP, 200 mg and 400 mg

Mumbai, June 01, 2021. Glenmark Pharmaceuticals Limited (Glenmark) has launched Rufinamide Tablets USP, 200 mg and 400 mg, a therapeutic equivalent of Banzel®1 Tablets, 200 mg and 400 mg of Eisai, Inc. Glenmark More...

Live Updates COVID-19 CASES